Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
1992-10-22
pubmed:abstractText
We have created a bacterial expression-export system and have used it to express (14 mg l-1) the variable region fragment (Fv) of an anti-digoxin antibody (26-10) in Escherichia coli. The expression-export plasmid contains a T7 promoter and the E. coli signal sequences ompA [Movva et al., J. biol. Chem. 255, 27-29 (1980)] and phoA [Inouye et al., J. Bacteriol. 149, 434-439 (1982)] fused to heavy chain (VH) and light chain (VL) variable region sequences to generate an artificial cistron. The 26-10 Fv protein made using this system was soluble, unlike many other expression systems which produce insoluble proteins in the form of inclusion bodies. The 26-10 VH and VL proteins were cleaved at their mature N-termini and exported into the bacterial periplasm where they could be easily extracted and affinity purified on ouabain-Sepharose. 26-10 Fv bound to digoxin with similar affinity and specificity as the whole 26-10 antibody (Ka for Fv, 1.3 x 10(9) M-1, Ka for IgG, 7 x 10(9) M-1). 26-10 Fv appears to be remarkably stable in comparison with other Fv fragments. The half-life for chain dissociation of 26-10 Fv was 48 hr compared to the reported 1.5 hr half-life of McPC603 Fv. We present the proton NMR spectra of the 26-10 Fv as preliminary evidence that this expression-export system can be used to facilitate the analysis of the solution structure of 26-10 Fv by NMR.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0161-5890
pubmed:author
pubmed:issnType
Print
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1237-47
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:1528194-Amino Acid Sequence, pubmed-meshheading:1528194-Antibody Affinity, pubmed-meshheading:1528194-Antibody Specificity, pubmed-meshheading:1528194-Bacterial Outer Membrane Proteins, pubmed-meshheading:1528194-Bacterial Proteins, pubmed-meshheading:1528194-Cloning, Molecular, pubmed-meshheading:1528194-Digoxin, pubmed-meshheading:1528194-Electrophoresis, Polyacrylamide Gel, pubmed-meshheading:1528194-Escherichia coli, pubmed-meshheading:1528194-Gene Expression Regulation, Bacterial, pubmed-meshheading:1528194-Genetic Vectors, pubmed-meshheading:1528194-Immunoglobulin G, pubmed-meshheading:1528194-Immunoglobulin Heavy Chains, pubmed-meshheading:1528194-Immunoglobulin Light Chains, pubmed-meshheading:1528194-Immunoglobulin Variable Region, pubmed-meshheading:1528194-Magnetic Resonance Spectroscopy, pubmed-meshheading:1528194-Molecular Sequence Data, pubmed-meshheading:1528194-Polymerase Chain Reaction, pubmed-meshheading:1528194-Promoter Regions, Genetic, pubmed-meshheading:1528194-Radioimmunoassay, pubmed-meshheading:1528194-Recombinant Proteins
pubmed:year
1992
pubmed:articleTitle
Production of stable anti-digoxin Fv in Escherichia coli.
pubmed:affiliation
Bristol-Myers Squibb Pharmaceutical Research Institute, Department of Molecular Biology of Macromolecules, Princeton, NJ 08543.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.